Related Experiment Video
Updated: Jul 18, 2026
09:05
Imaging Ca2+ Dynamics in Cone Photoreceptor Axon Terminals of the Mouse Retina
Published on: May 6, 2015
Calpain activity in retinal degeneration
François Paquet-Durand1, Leif Johnson, Per Ekström
1Ophthalmology Department, University of Lund, Lund, Sweden. francois.paquet-durand@med.lu.se
Journal of Neuroscience Research
|December 16, 2006
Summary
Calpain activation contributes to retinal degeneration, a leading cause of blindness. Calpain inhibitors may offer a therapeutic strategy to prevent or slow vision loss in conditions like retinitis pigmentosa and glaucoma.
Area of Science:
- Neuroscience
- Ophthalmology
- Cell Biology
Background:
- Retinal degenerations, including retinitis pigmentosa (RP) and glaucoma, are significant causes of human blindness.
- Understanding the molecular mechanisms of retinal cell death is crucial for developing effective therapies.
- Calpain, a calcium-dependent protease, is implicated in neuronal cell death, including in the retina.
Purpose of the Study:
- To review methods for detecting calpain activity.
- To discuss the role of calpains in various cell death pathways.
- To explore the potential involvement of calpains in retinal degeneration and the therapeutic implications of calpain inhibitors.
Main Methods:
- Overview of current methods for detecting calpain activity.
- Review of scientific literature on calpain function in cell death.
- Analysis of existing research on retinal degeneration and calpain involvement.
Main Results:
- Calpain activation is a potential contributor to cell death in retinal degenerative diseases.
- Improved detection of calpain activity can identify new pathological conditions.
- Calpain inhibitors show promise as a therapeutic approach for retinal degeneration.
Conclusions:
- Calpains play a significant role in retinal cell death mechanisms.
- Targeting calpains with inhibitors could offer a novel strategy to treat or prevent blindness caused by retinal degeneration.
- Further research into calpain activity in retinal diseases is warranted.
